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anglais
Summary Young mice over-expressing Runx2 fail to gain bone relative to wild type
mice with growth and present spontaneous fractures. It allows, for the first time in
rodents, direct assessment of anti-fracture efficacy of strontium ranelate which was
able to decrease caudal vertebrae fracture incidence through an improvement of
trabecular and cortical architecture. Introduction The aim was to investigate
whether strontium ranelate was able to decrease fracture incidence in mice over-
expressing Runx2, model of severe developmental osteopenia associated with
spontaneous vertebral fractures. Methods Transgenic mice and their wild type
littermates were treated by oral route with strontium ranelate or vehicle for 9 weeks.
Caudal fracture incidence was assessed by repeated X-rays, resistance to
compressive loading by biochemical tests, and bone microarchitecture by
histomorphometry. Results Transgenic mice receiving strontium ranelate had
significantly fewer new fractures occurring during the 9 weeks of the study (−60%, p
< 0.05). In lumbar vertebrae, strontium ranelate improves resistance to compressive
loading (higher ultimate force to failure, +120%, p < 0.05) and trabecular
microarchitecture (higher bone volume and trabecular number, lower trabecular
separation, +60%, +50%, −39%, p < 0.05) as well as cortical thickness (+17%, p <
0.05). In tibiae, marrow cavity cross-section area and equivalent diameter were
lower (−39%, −21%, p < 0.05). The strontium level in plasma and bone was in the
same range as the values measured in treated postmenopausal women. Conclusions
This model allows, for the first time, direct assessment of anti-fracture efficacy of
strontium ranelate treatment in rodents. In these transgenic mice, strontium
ranelate was able to decrease caudal vertebral fracture incidence through an
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